The clinical Alzheimer's disease spectrum classified in the A/T/N framework with 18F-Flutemetamol-Centiloid, 18F-MK-6240-CenTauR, and 18F-FDG-AD metaROI: a multicenter memory clinic observational study
Vere Rose Megens, Peter Wessel Strandhagen, Erik Magnus Berntsen, Ebba Gløersen Müller, Koen Van Laere, Live Eikenes, Asta K Haberg, 180˚N Cognitive Impairment Group · 2026
Read The clinical Alzheimer's disease spectrum classified in the A/T/N framework with 18F-Flutemetamol-Centiloid, 18F-MK-6240-CenTauR, and 18F-FDG-AD metaROI: a multicenter memory clinic observational study by Vere Rose Megens, Peter Wessel Strandhagen, Erik Magnus Berntsen, Ebba Gløersen Müller, Koen Van Laere, Live Eikenes, Asta K Haberg, 180˚N Cognitive Impairment Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13421203.txt.
Description
Vere Rose Megens and a large team studied in 2026 how brain scans can sort people on the Alzheimer's disease path. They used three kinds of PET scans, each tied to one part of a standard scheme: amyloid buildup, tau buildup, and nerve cell loss. Patients came from memory clinics with mild memory trouble or mild dementia.
Tau buildup was more common in the dementia group than in the milder group. Higher levels of each scan marker went with worse scores on memory and thinking tests, though the links differed by test. The authors show that set cut-off values on standard scales can describe patients in a shared, clear way across centers.
Catalog record
| CREATOR | Vere Rose Megens, Peter Wessel Strandhagen, Erik Magnus Berntsen, Ebba Gløersen Müller, Koen Van Laere, Live Eikenes, Asta K Haberg, 180˚N Cognitive Impairment Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |